Oncology Grand Rounds Series: Part 5 — Myeloproliferative Neoplasms

Oncology Grand Rounds Series: Part 5 — Myeloproliferative Neoplasms
A satellite symposium held at the 2017 ONS Annual Congress

Oncology Grand Rounds Series:
Part 5 — Myeloproliferative Neoplasms

01:24 minutes | 1.6 Contact hours.

Video proceedings from the fifth in a series of 7 integrated symposia held at the 2017 ONS Annual Congress. Featuring perspectives from Ms Jenny Dahl, Dr Aaron T Gerds, Ms Emily A Knight, Dr Daniel A Pollyea and Ms Sarah K Swanson.

To complete the Post-test and Educational Assessment and Credit Form, click here. A statement of CNE credit will be issued for scores of 80% or better. Your statement of credit will be mailed to you within 3 weeks or may be printed online.

Related links:

Introduction
71-year-old man with postpolycythemia vera (post-PV) myelofibrosis (MF) who was initiated on ruxolitinib with excellent response
70-year-old woman with post-PV MF and a recent increase in leukocytosis and splenomegaly
47-year-old woman with PV and a concurrent diagnosis of cervical cancer
59-year-old woman diagnosed at age 50 with JAK2 mutation-positive PV that has become more symptomatic over the years
50-year-old man with essential thrombocythemia (ET) with CALR mutation and a family history of acute myeloid leukemia
53-year-old woman diagnosed with ET in 2006 with platelet counts higher than 1 million
Review additonal nursing video education programs:
Non-Small Cell Lung Cancer
2.2 Contact hours
Cancer Immunotherapy
1.6 Contact hours
Breast Cancer
1.6 Contact hours
Lymphomas and Chronic Lymphocytic Leukemia
2.2 Contact hours
Ovarian Cancer
1.75 Contact hours
Gastrointestinal Cancers
2.1 Contact hours